TK Insulin Syringe with/without Saftey Retractable Device
K-Number: K191639 · 2020-09-11
Decision Date2020-09-11
Product CodeMEG
Advisory CommitteeHO
DecisionSubstantially Equivalent
Device Summary
TK Insulin Syringe with/without Saftey Retractable Device is a medical device manufactured by Anhui Tiankang Medical Technology Co., Ltd.. It received FDA 510(k) clearance on 2020-09-11 under approval number K191639. The device is classified under product code MEG. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the TK Insulin Syringe with/without Saftey Retractable Device?
TK Insulin Syringe with/without Saftey Retractable Device is a medical device that received FDA 510(k) clearance on 2020-09-11. It is manufactured by Anhui Tiankang Medical Technology Co., Ltd.. The 510(k) number is K191639.
When was TK Insulin Syringe with/without Saftey Retractable Device approved by the FDA?
TK Insulin Syringe with/without Saftey Retractable Device received FDA 510(k) clearance on 2020-09-11, under approval number K191639.
What company makes TK Insulin Syringe with/without Saftey Retractable Device?
TK Insulin Syringe with/without Saftey Retractable Device is manufactured by Anhui Tiankang Medical Technology Co., Ltd..
What is the FDA product code for TK Insulin Syringe with/without Saftey Retractable Device?
The FDA product code for TK Insulin Syringe with/without Saftey Retractable Device is MEG.
Related Clinical Trials
NCT07613762
High-Flow Nasal Cannula on Exercise Tolerance in Heart Failure Patients Undergoing Cardiac Rehabilitation.
NOT_YET_RECRUITING
NCT07606495
Impact on Prognosis of Increased Sleep Quality Obtained by Personalized Night-time Nursing Care in Critically Ill Patients
NOT_YET_RECRUITING
NCT04426188
" Acute Brain Changes After Repetitive Headers in Soccer and the Effects of a Protective Device "
COMPLETED
NCT07611721
Evaluate the Performance of the Dexcom G7 Continuous Glucose Monitoring (CGM) System in Critically Ill Patients Undergoing Major Abdominal Surgery and Solid Organ Transplantation Which Require Blood Glucose Monitoring for Intensive Insulin Therapy.
RECRUITING
NCT07611643
Bruxism Therapy of Facial Pain
RECRUITING
NCT07284511
A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar
RECRUITING
Related PubMed Literature
PMID: 42181028
Systematic biocompatibility assessment of 4-µm surface silicone implants.
Biomaterials and biosystems (2026)
PMID: 42024289
Signal Detection Using Change Point Analysis to Identify Safety Signals from Spontaneous Reports in Aortic Stent Grafts in Japan.
Journal of medical systems (2026)
PMID: 41970523
Large language models in healthcare quality management: a European perspective on process automation and compliance.
Frontiers in digital health (2026)
PMID: 41613162
Evaluating Translational AI: A Two-Way Moving Target Problem.
NEJM AI (2025)
Other Devices by Anhui Tiankang Medical Technology Co., Ltd.
Related Devices (Code: MEG)
K1620300.5ml Sol-Care Retractable Safety Syringe with Fixed NeedleSol-Millennium Medical, Inc.
K152606Jeesung Safety Syringe and Single Use NeedlesJeesung Medical Co., Ltd.
K152808U&U Insulin Syringe with/without Safety Retractable DeviceU&U Medical Technology Co, Ltd.
K170651Sterile Disposable Syringe with Safety Needle, Sterile Disposable Syringe with Needle, Sterile Disposable Syringe, Sterile Disposable Safety Needle, Sterile Disposable NeedleYangzhou Medline Industry, Co., Ltd.
K163162Sterile Hypodermic Safety Syringes for Single UseJiangxi Hongda Medical Equipment Group , Ltd.
K163511NovaGuard SA Pro Safety SystemWest Pharmaceutical Services, Inc.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.